Viramune and Respiratory rate increased - a phase IV clinical study of FDA data

Summary:

Respiratory rate increased is reported as a side effect among people who take Viramune (nevirapine), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Combivir, and have Anaemia.

The phase IV clinical study analyzes which people have Respiratory rate increased when taking Viramune. It is created by eHealthMe based on reports of 11,323 people who have side effects when taking Viramune from the FDA, and is updated regularly.

What is Viramune?

Viramune has active ingredients of nevirapine. It is often used in hiv infection. eHealthMe is studying from 11,381 Viramune users. Check the latest studies of Viramune.

What is Respiratory rate increased?

Respiratory rate increased (excess breathing rate/min) is found to be associated with 880 drugs and 1,060 conditions by eHealthMe. Check the latest studies of Respiratory rate increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

11,323 people reported to have side effects when taking Viramune.
Among them, 26 people (0.23%) have Respiratory rate increased.

Could Viramune cause Respiratory rate increased?

Among these 26 people:

How long have people been on Viramune when they have Respiratory rate increased? *

What is the gender of people who have Respiratory rate increased when taking Viramune? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Respiratory rate increased when taking Viramune? *

What are other drugs people take besides Viramune? *

What are other side effects people have besides Respiratory rate increased? *

Hepatic Failure (liver failure): 12 people, 46.15%
Heart Rate Increased: 12 people, 46.15%
Hypotension (abnormally low blood pressure): 11 people, 42.31%
Nausea (feeling of having an urge to vomit): 8 people, 30.77%
Hepatic Necrosis (large portions of liver die off due to severe liver disease): 8 people, 30.77%
Fever: 7 people, 26.92%
Multi-Organ Failure (multisystem organ failure): 7 people, 26.92%
Nausea And Vomiting: 7 people, 26.92%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 7 people, 26.92%
Renal Tubular Necrosis (death of kidney tubules): 7 people, 26.92%

What are the existing conditions these people have? *

Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 1 person, 3.85%
Rickets (softening of bones): 1 person, 3.85%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.85%
Genital Herpes (herpes infection of genital): 1 person, 3.85%
Birth Control: 1 person, 3.85%
Anaemia (lack of blood): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Viramune and have Respiratory rate increased?

- Check whether Respiratory rate increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viramune:

Viramune (11,381 reports)

Browse all side effects of Viramune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory rate increased:

Respiratory rate increased (880 drugs)

Browse all the conditions that are associated with Respiratory rate increased:

Respiratory rate increased (1,060 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nevirapine (the active ingredients of Viramune) and Viramune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.